Filana Therapeutics, Inc. FLNA
0.45 USD 0.00 (+0.38%)
At closeNov 6, 2026, 7:14 PM EST
0.45 0.00 -0.11%
After hours · Nov 6, 7:14 PM ET
0.4257 Day range 0.4698
0.45 52-week range 3.39
- YTD
- -77.14%
- 1 year
- -84.71%
News
benzinga.com Filana Therapeutics Q3 EPS $(0.22) Beats $(0.24) Estimate Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is unchanged from the same period last year.
benzinga.com Filana Therapeutics Announces A Study Published By Yale Researchers Of New Preclinical Research On Simufilam Examined Simufilam's Impacts In Human Cell Line To Eliminate Tuberous Sclerosis Complex 2 Gene To Model Cellular Changes Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing simufilam for the treatment of Tuberous Sclerosis Complex